Wednesday, November 28, 2012

New AIDS cases worldwide still too high says ONE

The ONE organization has released a new study that looks into new AIDS cases worldwide. The charity says that new cases of AIDS are still to high to meet the Millennium Development Goal of 2015. The study says that there were 2.5 million new cases of AIDS in 2011. That is more than double the amount needed to meet the MDG.

From Reuters Alert Net, writer Anna Yukhananov gives us more on the study's content.
Progress over the past decade has cut the death toll for the disease, mainly due to better access to drugs that can both treat and prevent the human immunodeficiency virus (HIV) which causes AIDS, the United Nations said in its annual report last week.
But while access to treatment has improved, in 2011 there were 2.5 million new cases of HIV. That is more than double the target of having only 1.1 million people newly infected each year, said ONE, a charity co-founded by Irish rock star Bono, that is dedicated to fighting poverty and preventable disease.
There were 34 million people living with AIDS at the end of last year.
At current rates, the world will not reach targets to reverse the spread of AIDS until 2022, seven years behind schedule, according to ONE.
"We recognize the world has done wonders in (fighting AIDS) in the last 10 years. But 2015 is around the corner," said Michael Elliott, ONE's chief executive.
"Here's a moment to put your pedal to the metal and go for it."
Much of the gap is due to funding cuts in major donor countries. The UN estimates there is about a $6 billion AIDS funding gap each year. Countries also have not coordinated a global strategy to tackle the AIDS epidemic, such as targeting treatment to groups at highest risk.

1 comment:

Unknown said...

We recognize that some of the greatest challenges in fighting diseases of poverty are organizational and managerial, not scientific or medical. With offices in over 25 countries, we partner with governments on a wide range of issues including HIV AIDS Care, malaria, and maternal and child health, as well as strengthening in-country health systems, expanding human resources for health, and improving markets for medicines and the efficiency of health resource allocation.